PSGL-1: A New Player in the Immune Checkpoint Landscape

被引:102
|
作者
Tinoco, Roberto [1 ,2 ,3 ]
Otero, Dennis C. [1 ,2 ]
Takahashi, Amy A. [1 ,2 ]
Bradley, Linda M. [1 ,2 ]
机构
[1] Sanford Burnham Prebys Med Discovery Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA
[2] Sanford Burnham Prebys Med Discovery Res Inst, Natl Canc Inst NCI Designated Canc Ctr, La Jolla, CA 92037 USA
[3] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
SELECTIN GLYCOPROTEIN LIGAND-1; CD8(+) T-CELLS; P-SELECTIN; LEUKOCYTE ADHESION; FOLLICULAR HELPER; DIFFERENTIAL EXPRESSION; SPECIALIZED FORM; BONE-MARROW; IN-VIVO; RECRUITMENT;
D O I
10.1016/j.it.2017.02.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P-selectin glycoprotein ligand-1 (PSGL-1) has long been studied as an adhesion molecule involved in immune cell trafficking and is recognized as a regulator of many facets of immune responses by myeloid cells. PSGL-1 also regulates T cell migration during homeostasis and inflammatory settings. However, recent findings indicate that PSGL-1 can also negatively regulate T cell function. Because T cell differentiation is finely tuned by multiple positive and negative regulatory signals that appropriately scale the magnitude of the immune response, PSGL-1 has emerged as an important checkpoint during this process. We summarize what is known regarding PSGL-1 structure and function and highlight how it may act as an immune checkpoint inhibitor in T cells.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 50 条
  • [1] PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion
    Tinoco, Roberto
    Carrette, Florent
    Barraza, Monique L.
    Otero, Dennis C.
    Magana, Jonathan
    Bosenberg, Marcus W.
    Swain, Susan L.
    Bradley, Linda M.
    IMMUNITY, 2016, 44 (05) : 1190 - 1203
  • [2] Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1-Resistant Melanoma
    DeRogatis, Julia M.
    Viramontes, Karla M.
    Neubert, Emily N.
    Henriquez, Monique L.
    Guerrero-Juarez, Christian F.
    Tinoco, Roberto
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (05) : 612 - 625
  • [3] Targeting the PSGL-1 pathway for immune modulation
    Tinoco, Roberto
    Bradley, Linda M.
    IMMUNOTHERAPY, 2017, 9 (10) : 785 - 788
  • [4] PSGL-1 is a novel macrophage checkpoint in immuno-oncology.
    Nowakowska, Dominika
    Phennicie, Ryan
    Kauffman, Kevin
    Zafari, Mohammad
    Rooney, Kathryn
    O'Nuallain, Brian
    Sazinsky, Steve
    Wahle, Joe
    Feldman, Igor
    Novobrantseva, Tatiana
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy
    DeRogatis, Julia M.
    Viramontes, Karla M.
    Neubert, Emily N.
    Tinoco, Roberto
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] PSGL-1, an immune checkpoint regulator that promotes T cell exhaustion in chronic viral infection and cancer
    Tinoco, Roberto
    Carrette, Florent
    Barraza, Monique
    Magana, Jonathan
    Swain, Susan
    Bradley, Linda
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [7] PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells
    Viramontes, Karla M.
    Neubert, Emily N.
    DeRogatis, Julia M.
    Tinoco, Roberto
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] PSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea
    Diaz-Garcia, Elena
    Garcia-Sanchez, Aldara
    Alfaro, Enrique
    Lopez-Fernandez, Cristina
    Manas, Eva
    Cano-Pumarega, Irene
    Lopez-Collazo, Eduardo
    Garcia-Rio, Francisco
    Cubillos-Zapata, Carolina
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] PD-1 immune checkpoint blockade can synergize with PSGL-1 inhibition to reinvigorate exhausted T cells
    Viramontes, Karla M.
    Neubert, Emily N.
    DeRogatis, Julia M.
    Henriquez, Monique
    Tinoco, Roberto
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [10] PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion (vol 44, pg 1190, 2016)
    Tinoco, Roberto
    Carrette, Florent
    Barraza, Monique L.
    Otero, Dennis C.
    Magana, Jonathan
    Bosenberg, Marcus W.
    Swain, Susan L.
    Bradley, Linda M.
    IMMUNITY, 2016, 44 (06) : 1470 - 1470